全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 209799-67-7 | Forodesine;Fodosine; Immucillin-H; 7-[(2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | C11H14N4O4 |
| 209803-40-7 | N,N-Diisopropyl-1,5-Pentanediamine;(5-aminopentyl)bis(methylethyl)amine;5-(Diisopropylamino)amylamine;5-(Diisopropylamino)pentylamine | C11H26N2 |
| 209804-25-1 | 5-(Bromomethyl)-1H-indazole-1-carboxylic acid 1,1-dimethylethyl ester | C13H15BrN2O2 |
| 209858-74-2 | 6-Chloro-4-methylpyridine-2-carbonitrile | C7H5ClN2 |
| 209860-87-7 | Tafluprost;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 1-methylethyl ester | C25H34F2O5 |
| 209860-88-8 | Tafluprost (free acid);AFP 172 | C22H28F2O5 |
| 209861-00-7 | (3aR,4R,5R,6aS)-5-(Benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one | C24H22F2O5 |
| 209861-01-8 | (3aR,4R,5R,6aS)-4-[(1E)-3,3-Difluoro-4-phenoxy-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one | C17H18F2O4 |
| 209863-09-2 | 3'-Methoxybiphenyl-4-carboxaldehyde;3'-Methoxy-[1,1'-biphenyl]-4-carboxaldehyde | C14H12O2 |
| 209909-13-7 | 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde | C10H4ClF2NO |
| 209912-44-7 | Methyl 4-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Benzoate;Methyl 4-(3-methyl-1,2,4-oxadiazol-5-yl)benzoate 97+%;Methyl4-(3-methyl-1,2,4-oxadiazol-5-yl)benzoate;MFCD08690288 | C11H10N2O3 |
| 209917-48-6 | N-tert-Butyl-4-aminobenzenesulfonamide | C10H16N2O2S |
| 209917-92-0 | 2'-(Trifluoromethyl)-3-Biphenylamine;2'-Trifluoromethylbiphenyl-3-ylamine;2'-Trifluoromethyl-biphenyl-3-ylamine;ZINC02574105 | C13H10F3N |
| 209919-30-2 | 4-Chloro-2-methylphenylboronic acid | C7H8BClO2 |
| 209920-43-4 | 6-Methylindole-3-carboxylic acid;6-Methyl-1H-indole-3-carboxylic acid | C10H9NO2 |
| 209958-42-9 | N-Boc-4-Bromo-2-fluoroaniline;(4-Bromo-2-fluorophenyl)carbamic acid tert-butyl ester | C11H13BrFNO2 |
| 209959-33-1 | (5-Bromopyrimidin-2-yl)bis(tert-butoxycarbonyl)amine;Imidodicarbonic acid 2-(5-bromo-2-pyrimidinyl)-1,3-bis(1,1-dimethylethyl) ester | C14H20BrN3O4 |
| 209960-91-8 | 2-Methoxy-4-(morpholin-4-yl)aniline;2-Methoxy-4-morpholinoaniline; 2-Methoxy-4-morpholinobenzenamine | C11H16N2O2 |
| 209962-07-2 | 2-BroMo-1-(Morpholinocarbonyl)benzene | |
| 209963-04-2 | (betaR)-beta-Amino-3-bromobenzeneethanol | C8H10BrNO |
| 209963-05-3 | (betaS)-beta-Amino-3-bromobenzeneethanol | C8H10BrNO |
| 209980-47-2 | N,N'-Bis[4-(1-naphthalenylphenylamino)phenyl]-N,N'-diphenyl-[1,1'-biphenyl]-4,4'-diamine | C68H50N4 |
| 209982-56-9 | 2-Ethyl-2-adamantyl methacrylate | C16H24O2 |
| 209983-91-5 | (3S)-3-Aminohexahydro-1-benzyl-2H-azepin-2-one | C13H18N2O |
| 209983-96-0 | (3S)-3-Aminohexahydro-1-methyl-2H-azepin-2-one;3S)-3-Amino-1-methylazepan-2-one;L-alpha-Amino-omega-methyl-1-caprolactam | C7H14N2O |
| 209984-30-5 | 5,7-Dihydro-5-methyl-6H-dibenz[b,d]azepin-6-one | C15H13NO |
| 209984-56-5 | N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide | C26H23F2N3O3 |
| 209984-57-6 | LY 411575;(aS)-N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-alpha-hydroxybenzeneacetamide | C26H23F2N3O4 |
| 209986-17-4 | N-[(1S)-2-[[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide | C27H24F2N4O3 |
| 209991-62-8 | 3,4,5-Trifluorophenylacetic acid | C8H5F3O2 |
| 209991-63-9 | 2,4,6-Trifluorophenylacetic acid | C8H5F3O2 |
| 209991-64-0 | 2-Fluoro-4-(trifluoromethyl)phenylacetic acid | C9H6F4O2 |
| 209995-38-0 | 2,4,5-Trifluorophenylacetic acid | C8H5F3O2 |
| 210035-02-2 | Imidazo[1,2-a]pyridin-3-ylphenylmethanone;NSC 304613 | C14H10N2O |
| 210036-24-1 | 3-O-(2-Acetamido-2-Deoxyhexopyranosyl)Hexopyranose;3-O-[2-AC<wbr>ETAMIDO-2<wbr>-DEOXY-Î’<wbr>-D-GLUCOP<wbr>YRANOSYL]<wbr>-D-MANNOP<wbr>YRANOSE | C14H25NO11 |
| 210037-23-3 | (4-Iodo-2-Methoxyphenyl)Methanol;(4-iodo-2-methoxyphenyl)methanol | C8H9IO2 |
| 210037-58-4 | 5-Bromopyrazinecarboxylic acid methyl ester;5-Bromo-2-pyrazinecarboxylic acid methyl ester | C6H5BrN2O2 |
| 210039-65-9 | 2-Hydroxy-5-(trifluoromethyl)benzaldehyde;2-Hydroxy-5-trifluoromethylbenzaldehyde; 5-Trifluoromethyl-2-hydroxybenzaldehyde | C8H5F3O2 |
| 210050-83-2 | (3R)-3,4-Dihydro-2',2'-dimethyl-[3,8'-bi-2H-1-benzopyran]-5',7-diol;Erythbidin A | C20H20O4 |
| 210057-23-1 | (-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate | C26H40P2Rh.BF4 |
| 210095-55-9 | (R)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine | C17H19ClN2O |
| 210095-58-2 | 2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine (2R,3R)-2,3-Dihydroxybutanedioate;(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate | C17H19ClN2O.C4H6O6 |
| 210095-66-2 | N-Acetyl-L-phenylalanine compd. with 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]pyridine (1:1);(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (S)-2-acetamido-3-phenylpropanoate | C17H19ClN2O.C11H13NO3 |
| 210101-16-9 | Conivaptan;N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide | C32H26N4O2 |
| 210107-38-3 | 3-(4-Iodophenyl)-3-(trifluoromethyl)-3H-diazirine | C8H4F3IN2 |
| 210110-90-0 | Miglustat hydrochloride;(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride | C10H22ClNO4 |
| 210169-05-4 | 3-Amino-5-fluoropyridine | C5H5FN2 |
| 210169-07-6 | 3,5-Difluoropyridine 1-oxide | C5H3F2NO |
| 210169-13-4 | 2,6-Dibromo-3,5-difluoropyridine | C5HBr2F2N |
| 210169-40-7 | (S)-5,5'-Bis[bis(3,5-di-tert-butyl-4-methoxyphenyl)phosphino]-4,4'-bibenzodioxole;(S)-(+)-DTBM-SEGPHOS | C74H100O8P2 |